Vertical: HealthcareBase Year: 2018
Market Size (2018)
$1.16B
Projected (2025)
$2.02B
CAGR (2016–2025)
7.7%
Key Players
10+
Perfusion radiology is an imaging test that shows how the blood flows through the organs or tissues. This test is used for the diagnosis of various chronic disorders. Growing prevalence of cardiovascular and neurological diseases, increasing geriatric population, and advancements in technology are driving the growth of the global perfusion radiology market. However, stringent regulatory policies and lack of awareness for the use of advanced technologies are likely to hamper the market growth
Key Contributing Factors
There are numerous factors that contribute to the growth of the perfusion radiology market. The key factors are mentioned below in brief.
Growing Prevalence of Cardiovascular and Neurological Diseases
According to the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, in 2017, every year about 795,000 people in the US have a stroke of which about 610,000 are new reported cases of strokes and185,000 are recurrent strokes.
Increasing Geriatric Population
According to the Economic and Social Commission for Asia and the Pacific (ESCAP) in 2016, approximately 12.4% of the population in the region was 60 or older, however, this is projected to increase to over a quarter or to 1.3 billion people by 2050.
Advancements in Technology
Coronary computed tomography angiography (CTA) combined with computed tomography perfusion (CTP) imaging holds immense potential to evaluate all aspects of the broad spectrum of ischemic heart disease. This helps in disease diagnosis and deciding appropriate treatment for the patient.
The Perfusion Radiology Market market is projected to grow at a CAGR of 7.7% from 2016 to 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe scope of the global perfusion radiology market study includes the market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on application, end user, and region.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe global perfusion radiology market is characterized by the presence of global, regional, and local vendors. The market is highly competitive with all players competing to gain maximum market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products, to survive and succeed in an intensely competitive and growing market environment.
The growth of market vendors is dependent on market conditions, government support, and industry development. Thus, vendors should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional, and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that improvement of the global economic scenario combined with efforts to enhance infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new products and to increase the global market share. Vendors with better technical and financial resources could develop innovative products. Therefore, vendors must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their treatment lines in the market.
Bargaining Power of Suppliers
Bargaining power of suppliers in the global perfusion radiology market is low to moderate. The suppliers in the global perfusion radiology industry are medical device manufacturers. Currently, a high number of suppliers are present in the market due to high opportunities. Major players are accounting for a significant share of the market. Switching cost of the suppliers is moderate because suppliers tend to enter into long-term associations, partnership, and deals with the companies that sell perfusion radiology devices.
Bargaining Power of Buyers
The bargaining power of the buyers is moderate to high in the global perfusion radiology market due to the presence of many suppliers of perfusion radiology devices. The buyers of perfusion radiology are moderately inclined towards product manufacturers. The market consists of high number of manufacturers, which leads to many options with regards to the product offering. Thus, the bargaining power of buyers tends to be moderate to high in this market.
Threat of New Entrants
The threat of new entrants is low to moderate in the global perfusion radiology market. Any company trying to enter the perfusion radiology market is required to accept the regulatory standards and product should get approval by regulatory authorities. This market is also characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for new entrants. Moreover, products which are already available in the market are patented, and the cost involved in R&D is high, which creates unfavorable conditions for the new entrants in the market.
Threat of Substitutes
The threat of substitutes in the global perfusion radiology market is low. Substitutes pose a low threat in the global perfusion radiology market due to the unavailability of similar products which are offered by major market players. The techniques used in perfusion radiology imaging are ultrasound, MRI, and X-ray amongst others. Due to availability of limited perfusion radiology techniques, the threat of substitutes in the global perfusion radiology market is low.
Intensity of Rivalry
The degree of competition in the global perfusion radiology market is high. Many manufacturers are present in the market. The market is shared by many major players, and their market share is fixed, which indicates the intense rivalry. Players are engaged in developing a process to lower their manufacturing cost to overcome the competition. Moreover, the players are also developing advanced techniques to differentiate their product from their rivals.
Market estimates by geography (2025)
InsightAmericas leads with $3.68B by 2025, while Asia Pacific is projected to grow fastest at a 7.7% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $1.03B | $1.44B | $2.02B | 7.7% | 20% |
| Americas | $2.07B | $2.82B | $3.68B | 6.6% | 37% |
| Europe | $1.88B | $2.58B | $3.50B | 7.2% | 36% |
| Middle East and Africa | $398.02M | $477.37M | $654.90M | 5.7% | 7% |
| Total | $5.38B | $7.32B | $9.86B | 7.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$2.02B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Hospitals | $5.82B | 7.3% | 59% |
| Diagnostic Centers | $3.14B | 7.1% | 32% |
| Others | $904.94M | 4.6% | 9% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Perfusion Radiology Market covering market dynamics, competitive landscape, and strategic outlook.
The Perfusion Radiology Market market is projected to reach $2.02B by 2025, growing at 7.7% CAGR. The Hospitals segment holds the largest share.
Perfusion is the passage of fluids through the blood vessels or the lymphatic system to the organs or tissues. The practice of perfusion radiology is the process by which the perfusion can be observed, recorded, and quantified. The term perfusion radiology encompasses a wide range of medical imaging modalities. Perfusion radiology may involve radioactive materials called tracers, which are mixed with blood and are absorbed into the organ to be studied. A special gamma camera takes pictures of the organ, as blood flows through it, to reveal qualitative and quantitative changes.
The global perfusion radiology market is mainly driven by the growing prevalence of cardiovascular and neurological diseases, increasing geriatric population, and advancements in technology. High treatment cost, overpriced devices, and low hi-tech healthcare presence in lower-income countries are likely to restrain the growth of the market during the forecast period. On the other hand, recent technological advancements are likely to offer lucrative opportunities for the growth of the market.
Developing economies pose an opportunity for various markets as they have undeveloped research & development sectors due to which they would be unable to address complex health challenges. For instance, although there is a high demand for treatment, poor economic conditions lead to the slow growth of the healthcare industry in Africa. Moreover, according to the American Heart Association, Inc., in 2016, East Asia, Eastern Europe, and parts of Central Asia, Southeast Asia, and sub-Saharan Africa had the highest rate of mortality caused by stroke. Huge population affected by chronic diseases in developing countries reflects the need for various perfusion radiology tests, hence acting as a strong opportunity for key players operating in the perfusion radiology market.
Regulatory compliance is the primary hurdle that is challenging the perfusion radiology industry. The growing prevalence of ischemic heart diseases, as well as increased awareness regarding the benefit of perfusion radiology techniques among healthcare professionals,have contributed to the rapid increase in the demand for perfusion radiology for the diagnosis of various chronic disorders. Besides, Indian manufacturers are investing significantly in perfusion radiology products, in compliance with the US Food and Drug Association (FDA) regulations, to obtain manufacturing contracts from companies based in the US. Although these regulations serve to improve and maintain the quality of diagnostic tests, the stringency also contributes to curb the growth of the perfusion radiology market, especially in the developing regions such as the Asia-Pacific.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the Perfusion Radiology Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Company Headquarters: Shenyang, Liaoning China Founded: 1998 Workforce: 10,001 Company Working: Neusoft Corporation (Neusoft) deals in providing innovative information technology-enabled solutions and services to meet the unmet demands of its customers. Neusoft was established at Northeastern University, China. It has ten software research and development bases, eight regional headquarters, and a comprehensive marketing and service network covering over 60 cities across China, as well as subsidiaries in the US, Europe, Japan, the Middle East, and South America. It helps industry customers establish best practices in business development and management.
Siemens is Europe's largest industrial technology group and, on the evidence of its own fiscal 2025 accounts, one of the very few diversified industrials that has successfully converted a hardware conglomerate into a software-and-automation compounder without sacrificing scale. Revenue of €78.9 billion and net income of €10.4 billion in FY2025 sit alongside a €117 billion order backlog and a 42,400-strong patent estate. The company's structural advantage is the pairing of installed-base automation hardware — SIMATIC, SINAMICS, SENTRON, Trainguard — with a first-tier industrial software franchise built through Mentor Graphics, Altair and Dotmatics, monetized through the Siemens Xcelerator platform. The planned spin-off of Siemens Healthineers, scheduled for a shareholder vote in February 2027, will strip roughly €23 billion of revenue but leave a more focused, higher-multiple portfolio of Digital Industries, Smart Infrastructure and Mobility. The strategic bet is explicit: industrial AI, electrification of data centres, and doubling digital revenue by 2030. --- ### What Siemens does — the company's own characterization Siemens describes itself in its FY2025 corporate boilerplate as a technology company focused on industry, infrastructure, mobility and healthcare, whose stated purpose is to create technology to transform the everyday. The formulation Siemens uses consistently across FY2025–FY2026 filings is that it combines the real and the digital worlds to help customers accelerate digital and sustainability transformations — making factories more efficient, cities more liveable, and transport more sustainable. Since FY2024 the company has appended a claim to leadership in industrial AI, positioning its domain knowledge as the differentiator that makes generative and predictive AI usable in physical industrial settings. ### Independent characterization Siemens is best understood not as a conglomerate but as three tightly coupled franchises plus a soon-to-be-detached fourth: **(a) An automation installed-base business with a software annuity attached (Digital Industries).** The economic engine here is the sale of controllers, drives, CNCs and industrial networking hardware into discrete and process manufacturing, followed by decades of engineering-software attach. Siemens' EDA business (formerly Mentor Graphics) and its PLM/simulation stack (NX, Teamcenter, Simcenter, now Altair) are genuinely tier-one franchises competing head-on with Dassault Systèmes, PTC, Cadence and Synopsys — not adjuncts to hardware. Digital Industries software revenue reached €1,790 million in Q3 FY2026 alone, up 16% year-over-year. **(b) A late-cycle electrification and buildings business riding a structural capex wave (Smart Infrastructure).** This is currently Siemens' best-performing franchise, with Q3 FY2026 orders of €8,002 million, up 40% nominally and 42% comparably, driven explicitly by large data-centre contracts in the US and Europe. Q3 FY2026 profit margin reached 20.0%. This is the segment most directly levered to the AI-infrastructure buildout. **(c) A long-cycle project and systems business with multi-decade service tails (Mobility).** Rolling stock, rail infrastructure, signalling and maintenance contracts. Order intake is lumpy — Q3 FY2026 included a €2.2 billion Swiss double-deck train order, a €2.0 billion UK extended-maintenance contract, and a €0.6 billion German battery-train service contract — but converts into decades of high-visibility service revenue. **(d) A consolidated but exiting medtech business (Siemens Healthineers).** 69% owned at Sept 30, 2025; reduced to approximately 67% subsequently. Siemens intends to distribute 30 percentage points of that stake directly to shareholders and, over the medium term, reduce the residual holding to a financial asset. **(e) A captive finance arm (Siemens Financial Services).** Total assets of €33,365 million at June 30, 2026. SFS both supports industrial sales through equipment and project finance and runs a proprietary debt and equity book. Its Q3 FY2026 EBT of €238 million included a €156 million gain from selling a UK equity stake — a reminder that SFS earnings are structurally lumpier than industrial earnings. ### Revenue model and mix Siemens does not disclose a full product / service / subscription / licence split at group level. What is disclosed: The strategically important trend is Digital Industries' transition to a software-as-a-service model, which the Supervisory Board explicitly cited when extending Cedrik Neike's contract. SaaS conversion depresses reported revenue in transition years — a partial explanation for DI's FY2025 revenue decline of 4% against 8% order growth. ### Value chain position, customers and end markets Siemens sits at the specification and control layer of industrial value chains rather than at the commodity component layer. Its products are typically designed into customer plants, buildings, grids and rolling stock at the engineering stage, creating switching costs measured in years. **Customer types:** discrete manufacturers (automotive, electronics, machine building, aerospace); process industries (chemicals, pharmaceuticals, food and beverage, oil and gas, water); semiconductor and electronics designers (EDA); hyperscale and colocation data-centre operators; commercial and institutional building owners; electric utilities and distribution network operators; national and municipal rail operators and rolling-stock leasing companies; hospitals and diagnostic laboratories (via Healthineers); and life-sciences R&D organizations (via Dotmatics). **End markets served:** factory and process automation; industrial and engineering software; electrical distribution and low/medium-voltage electrification; data-centre power infrastructure; building automation, fire safety and security; e-mobility charging; grid software and automation; passenger and freight rail; medical imaging, diagnostics and radiation oncology; and equipment/project finance. **Geographic exposure (FY2025 revenue):** Europe/C.I.S./Africa/Middle East €36,933m (46.8%); Americas €25,758m (32.6%); Asia and Australia €16,224m (20.6%). Germany alone was €11,646m and the United States €22,097m — meaning the US is now Siemens' single largest country market by a factor of nearly two over its home market.
Company Headquarters: Eindhoven, Netherlands Founded: 2016 Workforce: ~1000 Company Working: Advantis Medical Imaging is a leading company in the production of medical imaging devices. It is a fully integrated life sciences company that provides research, product development, manufacturing, and distribution of medical technologies. It is an outstanding worldwide source of regenerative medicine technology, clinical research, education, and training for the constantly evolving healthcare industry. Its sole focus is on products that are based in medical imaging.
Company Headquarters: Ardmore, Pennsylvania, US Founded: 1988 Workforce: ~100 Company Working: Perimed is one of the leaders in manufacturing perfusion imaging devices. It provides instruments, software, and expertise to enable accurate assessment of the microcirculation. The company is involved in developing, manufacturing, and commercializing its pharmaceutical devices and biological products in the US. The products offered by it are laser doppler, laser speckle, and transcutaneous oxygen (tcpO2, TCOM), to name a few.
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
